
PrimoGAIA
PrimoGaia opens up a new pathway in Magnetic Resonance Imaging (MRI) by initiating the concept of in vivo “enzymatic imaging” for a better understanding of human physiology, early detection and prognosis of diseases, monitoring of therapeutic treatment.
The project
7 partners 4 countries H2020 FET Open |
Start: 01-12-2019 end: 31-05-2023 |
News
#magnetic resonance imaging (MRI), #dynamic nuclear polarization (DNP), #overhauser MRI (OMRI), #enzyme activity, #ultra-low field, #contrast agents, #inflammatory diseases, #enzymatic mapping, #cost efficient sytems, #medical engineering
Journal of Medicinal Chemistry: Neutrophil Elastase-Activatable Prodrugs Based on an Alkoxyamine Platform to Deliver Alkyl Radicals Cytotoxic to Tumor Cells
Published in Chemistry Europe
...Chemistry – A European Journal: Highly Sensitive “Off/On” EPR Probes to Monitor Enzymatic Activity
Published in Chemistry Europe
...PrimoGAIA 2nd Review meeting
The 2nd PrimoGAIA Project Review meeting was successfully held on 26th January 2022.
...